Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

INZY Stock Forecast, Price Targets, Chart, Dividends & Analysis

Inozyme Pharma Inc. logo

Inozyme Pharma Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

5.11
 
USD
  
-0.14
  
(-2.67%)
Previous close: 5.25  Open: 5.25  Bid: 5.04  Ask: 5.3
52 week range    
2.69   
   7.80
Mkt Cap: 352 M  Avg Vol (90 Days): 255,563
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Thursday 10th October 2024

Stock Rankings

45
MarketXLS Rank
60
Value
53
Technical
23
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

INZY Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-5.11-2.4-1.78-1.37
Basic EPS total-5.11-2.4-1.78-1.37
Basic weighted shares outstanding11 M24 M38 M52 M
Depreciation217000.0674000.0700000.0800000.0
DepreciationAndAmortization217000.0674000.0700000.0800000.0
Diluted EPS total-5.11-2.4-1.78-1.37
Diluted normalized net income/share-1.78-1.37
Diluted weighted shares outstanding11 M38 M52 M
GeneralAndAdministrativeExpense11 M19 M21 M21 M
Income before tax-56 M-57 M-67 M-71 M
Interest income370000.0211000.02 M8 M
InterestExpenseNonOperating262000.03 M
MiscOtherSpecialCharges247000.0-189000.0-319000.0-28000.0
Net income from total operations-56 M-57 M-67 M-71 M
NetIncomeCommonStockholders-56 M-57 M-67 M-71 M
NetIncomeContinuousOperations-56 M-57 M-67 M-71 M
NetNonOperatingInterestIncomeExpense370000.0211000.02 M5 M
Normalized income-45 M-56 M
Operating income-57 M-57 M-69 M-76 M
Operating income before depreciation (EBITDA)-57 M-56 M-66 M-67 M
OperatingExpense57 M57 M69 M76 M
Other income net-247000.0189000.0319000.0-28000.0
OtherGandA11 M19 M21 M21 M
OtherOperatingExpenses700000.0700000.0700000.0900000.0
Research & development expense46 M38 M48 M55 M
ResearchExpense46 M38 M48 M55 M
SalariesAndWages400000.0
Selling Gen & administrative expense11 M19 M21 M21 M
Total Income available for interest expense (EBIT)-57 M-57 M-67 M-68 M
Total common shares outstanding23 M24 M44 M
Total net income-56 M-57 M-67 M-71 M
Total ordinary shares63 M63 M63 M63 M
TotalExpenses57 M57 M69 M76 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University